OrthoPediatrics Corp. Announces the Appointment of Kelly Fischer to its Board of Directors
OrthoPediatrics (NASDAQ: KIDS), a company specializing in pediatric orthopedics, has appointed Kelly Fischer to its Board of Directors effective August 8, 2025. Fischer, currently serving as Senior Vice President and CFO of Cook Medical, brings over two decades of financial and operational experience in the medical device industry.
The appointment coincides with the retirement of Terry Schlotterback, who served the company for over fifteen years as Director and Chairman of the Board. Fischer, with her background as an Audit Manager at Ernst & Young and her leadership at Cook Medical, aims to support OrthoPediatrics' strategy of market expansion and technology advancement in pediatric orthopedic care.
OrthoPediatrics (NASDAQ: KIDS), azienda specializzata in ortopedia pediatrica, ha nominato Kelly Fischer nel suo Consiglio di Amministrazione con decorrenza dall'8 agosto 2025. Fischer, attualmente Senior Vice President e CFO di Cook Medical, apporta oltre vent'anni di esperienza finanziaria e operativa nel settore dei dispositivi medici.
La nomina coincide con il pensionamento di Terry Schlotterback, che ha servito la società per più di quindici anni come Direttore e Presidente del Consiglio. Con un passato come Audit Manager presso Ernst & Young e la sua leadership in Cook Medical, Fischer intende sostenere la strategia di OrthoPediatrics volta all'espansione del mercato e al progresso tecnologico nella cura ortopedica pediatrica.
OrthoPediatrics (NASDAQ: KIDS), compañía especializada en ortopedia pediátrica, ha designado a Kelly Fischer en su Junta Directiva con efecto desde el 8 de agosto de 2025. Fischer, que actualmente ocupa el puesto de Senior Vice President y CFO de Cook Medical, aporta más de veinte años de experiencia financiera y operativa en la industria de dispositivos médicos.
El nombramiento coincide con la jubilación de Terry Schlotterback, quien sirvió a la compañía durante más de quince años como Director y Presidente de la Junta. Con su experiencia como Audit Manager en Ernst & Young y su liderazgo en Cook Medical, Fischer busca apoyar la estrategia de OrthoPediatrics de expansión de mercado y avance tecnológico en la atención ortopédica pediátrica.
OrthoPediatrics (NASDAQ: KIDS)는 소아 정형외과 전문 기업으로서 Kelly Fischer를 2025년 8월 8일부로 이사회 이사로 임명했습니다. 현재 Cook Medical의 수석 부사장 겸 CFO인 Fischer는 의료기기 업계에서 20년 이상의 재무 및 운영 경험을 보유하고 있습니다.
이번 임명은 15년 이상 이사 및 이사회 의장으로 재직한 Terry Schlotterback의 퇴임과 동시에 이루어졌습니다. Ernst & Young의 감사 매니저 경력과 Cook Medical에서의 리더십을 가진 Fischer는 소아 정형외과 치료에서 시장 확장과 기술 발전을 지원할 계획입니다.
OrthoPediatrics (NASDAQ: KIDS), une société spécialisée en orthopédie pédiatrique, a nommé Kelly Fischer au sein de son conseil d'administration à compter du 8 août 2025. Fischer, actuellement Senior Vice President et CFO de Cook Medical, apporte plus de vingt ans d'expérience financière et opérationnelle dans l'industrie des dispositifs médicaux.
Cette nomination coïncide avec la retraite de Terry Schlotterback, qui a servi l'entreprise pendant plus de quinze ans en tant qu'administrateur et président du conseil. Forte de son expérience comme Audit Manager chez Ernst & Young et de son leadership chez Cook Medical, Fischer entend soutenir la stratégie d'OrthoPediatrics visant à étendre sa présence sur le marché et à faire progresser les technologies dans les soins orthopédiques pédiatriques.
OrthoPediatrics (NASDAQ: KIDS), ein auf Kinderorthopädie spezialisiertes Unternehmen, hat Kelly Fischer mit Wirkung zum 8. August 2025 in den Vorstand berufen. Fischer, derzeit Senior Vice President und CFO von Cook Medical, bringt mehr als zwanzig Jahre Finanz- und Betriebserfahrung in der Medizinproduktebranche mit.
Die Berufung fällt mit dem Ruhestand von Terry Schlotterback zusammen, der dem Unternehmen über fünfzehn Jahre als Direktor und Vorstandsvorsitzender gedient hat. Mit ihrer Tätigkeit als Audit Manager bei Ernst & Young und ihrer Führungsrolle bei Cook Medical will Fischer die Strategie von OrthoPediatrics zur Markterweiterung und technologischen Weiterentwicklung in der pädiatrischen Orthopädie unterstützen.
- None.
- None.
WARSAW, Ind., Aug. 25, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the appointment of Kelly Fischer to its Board of Directors effective as of August 8, 2025. The appointment was made concurrent with the announcement of the retirement of Terry Schlotterback from the OrthoPediatrics Board of Directors, effective as of August 8, 2025.
“We’re excited to welcome Kelly Fischer to the OrthoPediatrics Board of Directors. Her proven expertise in financial leadership at Cook Medical will be a significant asset as we execute our strategy and expand our impact on children’s lives,” said Mark Throdahl, Executive Chairman of the OrthoPediatrics Board of Directors. “At the same time, we extend our deepest appreciation to Terry for over fifteen years of leadership as a Director and Chairman of the Board. His unwavering service and dedication to the Company, along with his insight and guidance, have been instrumental in establishing OrthoPediatrics as a pioneer in the pediatric orthopedic space.”
OthoPediatrics’ newly appointed board member, Kelly Fischer, currently serves as the Senior Vice President and Chief Financial Officer of Cook Medical, a multibillion dollar medical device company. For over two decades at Cook Medical, Ms. Fischer has held roles of increasing responsibility in finance and operations. Prior to joining Cook Medical, Ms. Fischer was an Audit Manager at Ernst & Young and held various positions at Arthur Andersen. Ms. Fischer holds a bachelor’s degree in accounting from the Kelley School of Business at Indiana University.
“I am honored to join the OrthoPediatrics Board of Directors. The Company has demonstrated a steadfast commitment to the pediatric orthopedic field where it has advanced the standard of care since its inception,” said Kelly Fischer. “Leveraging my experience in the medical device industry, I am excited to support the strategy to help more kids by taking market share, launching new technologies and expanding the specialty bracing franchise in a capital efficient manner. It is a privilege to work alongside this talented team as we advanced towards helping one million kids.”
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 80 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit www.orthopediatrics.com. For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit www.opsb.com.
Investor Contact
Philip Trip Taylor
Gilmartin Group
philip@gilmartinir.com
415-937-5406
FAQ
Who is Kelly Fischer, the new board member of OrthoPediatrics (NASDAQ: KIDS)?
When did Kelly Fischer join OrthoPediatrics' Board of Directors?
Who did Kelly Fischer replace on OrthoPediatrics' board?
What is OrthoPediatrics' (NASDAQ: KIDS) business focus?
What experience does Kelly Fischer bring to OrthoPediatrics' board?
